Karnataka Antibiotics and Pharmaceuticals Limited

Karnataka Antibiotics and Pharmaceuticals Limited - pharma in Bangalore, Karnataka, India. FY 2026 financials & compliance.
CIN U24231KA1981GOI004145 Incorporated 13 March 1981 ROC Bangalore HQ Bangalore, Karnataka, India
Active Public Limited Union Government Company pharma
Revenue · FY 2022
₹479.24 Cr
▲ 11% YoY
Net profit · FY 2022
₹24.66 Cr
Net margin 5.1%
EBITDA · FY 2022
₹41.73 Cr
EBITDA margin 8.7%
Authorised capital
₹15 Cr
Registered with MCA
Paid-up capital
₹13.49 Cr
Issued & subscribed
Open charges
₹21.25 Cr
Satisfied ₹42.06 Cr
Company age
45 yrs
Est. 1981
Employees · EPFO
623
Provident fund records

About Karnataka Antibiotics and Pharmaceuticals Limited

Data last updated:

Karnataka Antibiotics and Pharmaceuticals Limited is a public limited union government company based in Bangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 March 1981 and has been in existence for over 45 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24231KA1981GOI004145. Its GSTIN is 29AAACK5675N1ZU (Karnataka). The company holds 26 GST registrations, of which 22 are active.

The company has an authorised share capital of ₹15 Cr and a paid-up capital of ₹13.49 Cr. It is led by directors including Anurag Danayak (Managing Director) and Harsh Gupta.

Its last annual general meeting (AGM) was held on 29 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Bangalore, Karnataka.

As per the financials filed for FY 2022, the company reported a revenue of ₹479.24 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹24.66 Cr (net margin 5.1%) and EBITDA of ₹41.73 Cr (EBITDA margin 8.7%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 5% over five years.

The company has about 623 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹21.25 Cr and satisfied charges of ₹42.06 Cr on record. Court records list 89 cases involving the company, including 39 filed by the company and 50 filed against it; 16 cases are pending. The company has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹12 Cr; the latest was in October 2012. Its 5 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 3 smaller; the largest is Cronus Pharma Specialities India Private Limited with revenue of ₹484.74 Cr.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kaplindia.com.

Company details

CIN U24231KA1981GOI004145
Registration Number 004145
Incorporation Date 13 March 1981
ROC Bangalore
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

CIN history

Karnataka Antibiotics and Pharmaceuticals has one previous CIN (Corporate Identification Number): U02423KA1981PTC004145. The current CIN is U24231KA1981GOI004145, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24231KA1981GOI004145Current
U02423KA1981PTC004145Previous

Contact details

Karnataka Antibiotics and Pharmaceuticals Limited's registered office is in Bangalore, Karnataka. Its website is kaplindia.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Arka The Businesscenter Plot No.37 Site No.34/4 Nttf Main Road Peenya Industrial Area, 2nd Phase, Bangalore, Karnataka, India – 560058
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Karnataka Antibiotics and Pharmaceuticals Limited, buy the company report.

Comprehensive company report
Karnataka Antibiotics and Pharmaceuticals Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Karnataka Antibiotics and Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Karnataka Antibiotics and Pharmaceuticals Limited, buy the company report.

Financials of Karnataka Antibiotics and Pharmaceuticals Limited

FY 2023 filings available

Karnataka Antibiotics and Pharmaceuticals Limited reported revenue of ₹479.24 Cr (up 11% YoY) for FY 2022.

Revenue · FY 2022
₹479.24 Cr ▲ 11%
Net profit · FY 2022
₹24.66 Cr margin 5.1%
EBITDA · FY 2022
₹41.73 Cr margin 8.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 9%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 8%
5 years · compounded
▼ 4%

Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 11% growth in the latest year. EBITDA rose 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹479.24 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹41.73 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹24.66 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profitability
EBITDA Margin8.7%
Net Profit Margin5.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Karnataka Antibiotics and Pharmaceuticals Limited, buy the company report.

Board of directors of Karnataka Antibiotics and Pharmaceuticals Limited

Karnataka Antibiotics and Pharmaceuticals has 6 current directors and 59 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Harsh GuptaDirector23 Jul 20242 Years 3 MonthsCurrent
Vijay Kumar SrivastavaNominee Director22 Jun 20233 Years 4 MonthsCurrent
Madhuchanda KarDirector21 Apr 20251 Years 6 MonthsCurrent
Khushboo GoelNominee Director24 Jan 20251 Years 9 MonthsCurrent
Anurag DanayakManaging Director03 Jul 20251 Years 4 MonthsCurrent
Kempaiah SrinivasDirector18 Jul 20251 Years 4 MonthsCurrent

Peer comparison

Karnataka Antibiotics and Pharmaceuticals Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Cronus Pharma Specialities India Private Limited₹484.74 Cr (FY 2025)64.0%Hyderabad, Telangana, India
Syncom Formulations (India) Limited₹482.45 Cr (FY 2025)74.0%Mumbai, Maharashtra, India
Karnataka Antibiotics and Pharmaceuticals Limitedthis company₹479.24 Cr (FY 2022)₹24.66 Cr5.1%11.0%623Bangalore, Karnataka, India
Adcock Ingram Limited₹463.95 Cr (FY 2025)8.0%Bangalre, Karnataka, India
Zee Laboratories Limited₹463.57 Cr (FY 2024)10.0%Delhi, India
Aristo Laboratories Private Limited₹461.43 Cr (FY 2025)10.0%Mumbai, Maharashtra, India

To see the full peer comparison of Karnataka Antibiotics and Pharmaceuticals Limited, buy the company report.

Auditor

Karnataka Antibiotics and Pharmaceuticals Limited is audited by Yoganandh & Ram LLP for the financial year 2022.

Auditor firmFinancial yearFirm registration number
Yoganandh & Ram LLPFY 2022005157S/S200052

Shareholding

The shareholding of Karnataka Antibiotics and Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Karnataka Antibiotics and Pharmaceuticals Limited, buy the company report.

Charges & borrowings

Open charges
₹21.25 Cr
Satisfied charges
₹42.06 Cr
Breakdown by lending institutions
Vijaya Bank₹13.90 Cr
State Bank of India₹7.35 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
07 Nov 200580061694Vijaya Bank₹13.9 CrOpen
06 May 200280061500State Bank of India₹7.35 CrOpen
11 May 2017100103447Vijaya Bank₹15 CrSatisfied
30 Apr 201010219419Vijaya Bank₹8 CrSatisfied
29 Mar 200680061693Vijaya Bank₹7 CrSatisfied

To see the full charge records of Karnataka Antibiotics and Pharmaceuticals Limited, buy the company report.

Total charge records: 15 View all charges

Deals & funding

Karnataka Antibiotics and Pharmaceuticals Limited has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹12 Cr; the latest was in October 2012.

Total deals
3
Funding rounds
2
Secondary share transfer
1
Disclosed funding
₹12 Cr

Deals on record (3 of 3)

WhenDealAmountParties
Oct 2012Funding round₹6 CrInvestors: The President of India, Karnataka State Industrial and Infrastructure Development Corporation Limited
Oct 2010Funding round₹6 CrInvestors: The President of India, Karnataka State Industrial and Infrastructure Development Corporation Limited
Oct 2009Secondary share transferUndisclosedBuyer: The President of India
Seller: Hindustan Antibiotics Limited

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Karnataka Antibiotics and Pharmaceuticals Limited was last rated by Care on 25 Nov 2025.

Rating agencyRated onRating
Care25 Nov 2025

To see the full credit ratings and regulatory alerts of Karnataka Antibiotics and Pharmaceuticals Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Karnataka Antibiotics and Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Karnataka Antibiotics and Pharmaceuticals Limited has a workforce of 623 employees on its EPFO records as of May 2026.

Employee count
623
Employee growth
-14.1%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27623
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Karnataka Antibiotics and Pharmaceuticals Limited, buy the company report.

GST

Karnataka Antibiotics and Pharmaceuticals has 26 GST registrations: 22 active and 4 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
26
Active
22
Cancelled / inactive
4
GSTINStateStatusRegistered on
29AAACK5675N1ZUKarnatakaActive01 Jul 2017
29AAACK5675N1D3KarnatakaActive06 Sep 2023
03AAACK5675N1Z8PunjabActive01 Jul 2017
04AAACK5675N1Z6ChandigarhActive01 Jul 2017

To see the full GST registrations and return filing status of Karnataka Antibiotics and Pharmaceuticals Limited, buy the company report.

Recent activity

Karnataka Antibiotics and Pharmaceuticals Limited has 63 board changes on record since 2007: 6 appointments and 57 cessations. The latest: Kempaiah Srinivas was appointed as Director on 18 Jul 2025.

Appointed
Kempaiah Srinivas was appointed as Director.
Appointed
Anurag Danayak was appointed as Managing Director.
Appointed
Madhuchanda Kar was appointed as Director.
Ceased
Madhuchanda Kar ceased to be Director.
Appointed
Khushboo Goel was appointed as Nominee Director.
Ceased
Satheesha Basavanakote Chandrappa ceased to be Nominee Director.
Appointed
Harsh Gupta was appointed as Director.
Ceased
Thichempully Krishnadas Anil Kumar ceased to be Nominee Director.
Ceased
Sunil Kumar Kaimal ceased to be Managing Director.
Ceased
Mamballi Rajaratnam Ravi ceased to be Nominee Director.
AGM
Karnataka Antibiotics And Pharmaceuticals Limited last Annual general meeting of members was held on 29 Sep 2023 as per latest MCA records.
Charges
A charge registered on 11 May 2017 via Charge ID 100103447 with Vijaya Bank was fully satisfied on 01 Aug 2023.

88 earlier events are in the company report.

Frequently asked questions

Karnataka Antibiotics and Pharmaceuticals is an active public limited union government company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 March 1981 (45+ years old) and is registered under CIN U24231KA1981GOI004145.

Karnataka Antibiotics and Pharmaceuticals has 6 current directors:

The latest financial statements of Karnataka Antibiotics and Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 29 September 2023. Year-wise statements from 2015 are in the company report.

The GSTIN of Karnataka Antibiotics and Pharmaceuticals is 29AAACK5675N1ZU, registered in Karnataka. The company has 26 GST registrations in all, of which 22 are active and 4 are cancelled or inactive. Other active GSTINs include 29AAACK5675N1D3 (Karnataka), 03AAACK5675N1Z8 (Punjab), 04AAACK5675N1Z6 (Chandigarh).

The CIN (Corporate Identification Number) of Karnataka Antibiotics and Pharmaceuticals is U24231KA1981GOI004145. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Karnataka Antibiotics and Pharmaceuticals has 89 court cases on record: 39 filed by the company and 50 filed against it. 16 are pending. Most are in the high courts.

Karnataka Antibiotics and Pharmaceuticals was incorporated on 13 March 1981, making it 45+ years old. It is registered with the Registrar of Companies, Bangalore.

Karnataka Antibiotics and Pharmaceuticals has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹12 Cr; the latest was in October 2012.

The peers of Karnataka Antibiotics and Pharmaceuticals by revenue are Cronus Pharma Specialities India Private Limited, Syncom Formulations (India) Limited, Adcock Ingram Limited, Zee Laboratories Limited, Aristo Laboratories Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Kempaiah Srinivas was appointed as Director on 18 Jul 2025. Anurag Danayak was appointed as Managing Director on 03 Jul 2025. Madhuchanda Kar was appointed as Director on 21 Apr 2025. Karnataka Antibiotics and Pharmaceuticals has 63 board changes on record in total.

Karnataka Antibiotics and Pharmaceuticals can be reached through the website kaplindia.com. Its registered office is in Bangalore, Karnataka, India.